CPHI Awards Open for Entries in Multiple Categories

News
Article

Three new awards have been added to the roster for 2023 and include some specific highlights that have occurred over the past few years.

The 20th CPHI Pharma Awards opened for entries on March 16, 2023, including three new categories to help reflect the increase in innovation in the industry.

The 2023 CPHI Pharma Awards are now open for entries and are set to celebrate global leaders across 12 categories, including development and manufacturing of devices and drugs, packaging, supply chain, sustainability, and regulatory compliance. Three new awards have been added to the roster for 2023 and include some specific highlights that have occurred over the past few years. For example, the new Start-up award was introduced to honor exhibitors from the start-up zone, and will span projects at proof-of-concept stage to prototype or commercial launch.

To further reflect wider efforts of many companies, the COVID Response category is being renamed the Accelerating Innovation award. The winner will be chosen based on innovations used to improve the impact of global healthcare emergencies or future health emergencies.

Lastly, the new Heart of Pharma award will celebrate the acceleration of social, ethical, and philanthropic activities. This will help to recognize the individuals, companies, or initiatives that have made the most noteworthy contributions to improving patient engagement or centricity, promoted corporate social responsibility and/or improvements to healthcare accessibility and equity.

The official list of CPHI Pharma Awards 2023 Categories:

Accelerating Innovation

API Development & Innovation

Finished Formulation

Manufacturing Excellence

Drug Delivery & Device Innovation

Packaging & Machinery

Supply Chain Excellence

Sustainability

Regulatory and Compliance

CEO of the Year

Start-Up Initiative

At the Heart of Pharma

To submit your entry, please visit the CPHI Pharma Awards website. Entries close on May 15, 2023.

Source: CPHI

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content